Taipei, Taiwan

Zong-Keng Kuo

This inventor holds 7 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Industrial Technology Research Institute. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zong-Keng Kuo. Retrieved from https://idiyas.com/inventor/zong-keng-kuo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 71.4

 

Average Co-Inventor Count = 6.5

ph-index = 1


Location History:

  • Zhonghe, TW (2014 - 2016)
  • New Taipei, TW (2017 - 2022)
  • Hsinchu, TW (2023)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Zong-Keng Kuo in Pharmaceutical Compositions

Introduction

Zong-Keng Kuo is an inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of inhibiting angiogenesis. His innovative approach focuses on utilizing lignans as effective ingredients in pharmaceutical formulations.

Latest Patent Applications

Zong-Keng Kuo has submitted a patent application titled "PHARMACEUTICAL COMPOSITIONS FOR INHIBITING ANGIOGENESIS." This application discloses a pharmaceutical composition that includes an effective amount of a lignan as an active ingredient. The composition may also contain a pharmaceutically acceptable carrier or salt. Furthermore, the application outlines a method for inhibiting angiogenesis by administering an effective amount of lignan to a subject in need.

Conclusion

Zong-Keng Kuo's work in developing pharmaceutical compositions for inhibiting angiogenesis showcases his innovative spirit and dedication to advancing medical science. His contributions may pave the way for new treatments in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…